An Update on C-reactive Protein for Intensivists

This review aims to summarise the physiology of C-reactive protein (CRP), its possible roles and limitations as an inflammatory and infective marker in intensive care medicine, and also the emerging roles of CRP in the pathogenesis of cardiovascular and autoimmune diseases. Observational and animal studies on uses of CRP were retrieved from the PubMed database without any language restrictions. Quantitative data were not pooled because of the heterogeneity of patient characteristics and disparate ways in which CRP was studied. Serum CRP concentrations are determined by the synthetic rate of its production in the liver regulated predominantly by interleukin-6. It has a half-life of 19 hours and is relatively slow in its onset and offset in response to an acute inflammatory process when compared to procalcitonin. It has some favourable properties and limitations as an inflammatory marker. An elevated CRP concentration is not specific to infections and the absolute CRP concentrations cannot be used to differentiate between bacterial, fungal and severe viral infections. The dynamic response of CRP to therapy that aims to modify the underlying inflammatory process and the clinical context of a patient are of pivotal importance when CRP concentrations are interpreted. CRP is found to be a significant partaker and prognostic factor in a wide range of cardiovascular and chronic diseases. In summary, CRP concentration is an important prognostic factor of many acute and chronic diseases. Serial CRP measurements may be useful to reflect a patient's response to therapy that aims to modify the underlying inflammatory process.

[1]  Herminia Navarro,et al.  Proteína C reactiva como marcador de infección en pacientes con traumatismo cerrado grave , 2001 .

[2]  H. M. Soliman,et al.  C-reactive protein levels correlate with mortality and organ failure in critically ill patients. , 2003, Chest.

[3]  T. M. Brown,et al.  C-reactive protein and serotonin syndrome. , 2004, The American journal of psychiatry.

[4]  M. Pepys,et al.  C-reactive protein and cardiovascular disease: new insights from an old molecule. , 2003, QJM : monthly journal of the Association of Physicians.

[5]  C. Visser,et al.  C-reactive protein activates complement in infarcted human myocardium. , 2003, The American journal of pathology.

[6]  H. Yoshikawa,et al.  Clinical implications of serum C‐reactive protein levels in malignant fibrous histiocytoma , 2002, International journal of cancer.

[7]  Larry W. Moreland,et al.  Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis , 2001 .

[8]  T. Holland-Letz,et al.  Estimation of the Mortality Risk of Surgical Intensive Care Patients Based on Routine Laboratory Parameters , 2008, European Surgical Research.

[9]  S. Rahman,et al.  Prognostic utility of postoperative C-reactive protein for posthepatectomy liver failure. , 2008, Archives of surgery.

[10]  M. Pepys,et al.  Solid phase radioimmunoassays for human C-reactive protein. , 1981, Clinica chimica acta; international journal of clinical chemistry.

[11]  A. Delgado,et al.  Hospital Malnutrition and Inflammatory Response in Critically Ill Children and Adolescents Admitted to a Tertiary Intensive Care Unit , 2008, Clinics.

[12]  J. Vincent,et al.  A prospective evaluation of the Infection Probability Score (IPS) in the intensive care unit. , 2008, The Journal of infection.

[13]  Theo Stijnen,et al.  Genetic Variation, C-Reactive Protein Levels, and Incidence of Diabetes , 2007, Diabetes.

[14]  K. Larsen,et al.  Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study , 2007, Critical care.

[15]  J. Michálek,et al.  Modeling effect of the septic condition and trauma on C-reactive protein levels in children with sepsis: a retrospective study , 2007, Critical care.

[16]  P. Póvoa.  Serum markers in community-acquired pneumonia and ventilator-associated pneumonia , 2008, Current opinion in infectious diseases.

[17]  L. Hansson,et al.  Use of Inflammatory Markers for Early Detection of Bacteraemia in Patients with Febrile Neutropenia , 2004, Scandinavian journal of infectious diseases.

[18]  S. Devaraj,et al.  C-Reactive Protein: Risk Marker or Mediator in Atherothrombosis? , 2004, Hypertension.

[19]  M. Di Napoli,et al.  C-Reactive Protein in Ischemic Stroke: An Independent Prognostic Factor , 2001, Stroke.

[20]  R. Gleason,et al.  Risk factors for thromboembolic events in renal failure. , 2004, International journal of cardiology.

[21]  Farzaneh A. Sorond,et al.  Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis , 2005, The Lancet Neurology.

[22]  Tong Liu,et al.  Meta-analysis of association between C-reactive protein and immediate success of electrical cardioversion in persistent atrial fibrillation. , 2008, The American journal of cardiology.

[23]  P. Malfertheiner,et al.  Markers for predicting severity and progression of acute pancreatitis. , 2008, Best practice & research. Clinical gastroenterology.

[24]  W. Lagrand,et al.  Localisation of C reactive protein in infarcted tissue sites of multiple organs during sepsis. , 2002, Journal of clinical pathology.

[25]  C. Urban,et al.  Non-infectious causes of elevated procalcitonin and C-reactive protein serum levels in pediatric patients with hematologic and oncologic disorders , 2008, Supportive Care in Cancer.

[26]  T. Chao,et al.  A cluster of patients with severe acute respiratory syndrome in a chest ward in southern Taiwan , 2004, Intensive Care Medicine.

[27]  S. Berliner,et al.  Early‐mid treatment C‐reactive protein level is a prognostic factor in aggressive non‐Hodgkin’s lymphoma , 2007, European journal of haematology.

[28]  A. Mert,et al.  Erythema Nodosum: An Experience of 10 Years , 2004, Scandinavian journal of infectious diseases.

[29]  P. Collinson,et al.  Markers of muscle ischemia, necrosis, and inflammation following uterine artery embolization in the treatment of symptomatic uterine fibroids. , 2007, American journal of obstetrics and gynecology.

[30]  Bruce M Psaty,et al.  Inflammation as a Risk Factor for Atrial Fibrillation , 2003, Circulation.

[31]  L. Kuller,et al.  Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. , 2004, Journal of the American Society of Nephrology : JASN.

[32]  C. Kallenberg,et al.  Autoantibodies against Protective Molecules—C1q, C‐Reactive Protein, Serum Amyloid P, Mannose‐Binding Lectin, and Apolipoprotein A1 , 2007, Annals of the New York Academy of Sciences.

[33]  C. Koegelenberg,et al.  Infective endocarditis: improving the diagnostic yield. , 2004, Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners.

[34]  J. Rello,et al.  C-reactive protein used as an early indicator of infection in patients with systemic inflammatory response syndrome , 2004, Intensive Care Medicine.

[35]  R. Hughes,et al.  Extent of the acute phase response in fulminant hepatic failure. , 1994, Gut.

[36]  M. Safar,et al.  Diagnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared with other clinical and biological variables. , 2002, Critical care medicine.

[37]  E. Kardeşoğlu,et al.  An independent prognostic factor for heart failure: sympathetic hyperactivity. , 2011, Chinese medical journal.

[38]  C. Olympios,et al.  The significance of circulating levels of both cardiac troponin I and high-sensitivity C reactive protein for the prediction of intravenous thrombolysis outcome in patients with ST-segment elevation myocardial infarction , 2007, Heart.

[39]  Ross J. Harris,et al.  Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis , 2009, Cancer Causes & Control.

[40]  K. Ho,et al.  C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: a prospective cohort study , 2008, Intensive Care Medicine.

[41]  J. Manson,et al.  Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. , 2002, JAMA.

[42]  Mark B Pepys,et al.  C-reactive protein: a critical update. , 2003, The Journal of clinical investigation.

[43]  J. Pankow,et al.  Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. , 2001, Atherosclerosis.

[44]  D. McMillan,et al.  The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer , 2004, British Journal of Cancer.

[45]  Yasmin,et al.  Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. , 2004, Arthritis and rheumatism.

[46]  M. Moneer,et al.  The Diagnostic Value of C-reactive Protein, Interleukin-8, and Monocyte Chemotactic Protein in Risk Stratification of Febrile Neutropenic Children With Hematologic Malignancies , 2007, Journal of pediatric hematology/oncology.

[47]  J. Alonso-Martínez,et al.  C‐reactive protein as a predictor of improvement and readmission in heart failure , 2002, European journal of heart failure.

[48]  S. Verma,et al.  Impaired endothelial function in C-reactive protein overexpressing mice. , 2008, Atherosclerosis.

[49]  J. Kline,et al.  Comparison of 8 biomarkers for prediction of right ventricular hypokinesis 6 months after submassive pulmonary embolism. , 2008, American heart journal.

[50]  E. Holler,et al.  Evaluation of C‐reactive protein, interleukin‐6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients , 2006, European journal of haematology.

[51]  S. Verma,et al.  C-Reactive Protein: Structure Affects Function , 2004, Circulation.

[52]  Patrick Nicolas,et al.  Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis , 2006, Critical care medicine.

[53]  K. Huber,et al.  Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock , 2003, Intensive Care Medicine.

[54]  J. Catineau,et al.  Evaluation of serum procalcitonin concentration in the ICU following severe burn. , 2007, Burns : journal of the International Society for Burn Injuries.

[55]  H. Zeidler,et al.  Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial , 2002, The Lancet.

[56]  T. D. Du Clos,et al.  Studies of serum C-reactive protein in systemic lupus erythematosus. , 2005, The Journal of rheumatology.

[57]  P. Bowness,et al.  Lesson of the week Difficulties in diagnosing acute rheumatic fever—arthritis may be short lived and carditis silent , 2000, BMJ : British Medical Journal.

[58]  P. Póvoa,et al.  Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study , 2006, Critical care.

[59]  F. Burzotta,et al.  Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients. , 2008, Cardiovascular revascularization medicine : including molecular interventions.

[60]  J. Jahnsen,et al.  C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study , 2008, Gut.

[61]  D. Altman,et al.  Diagnostic tests 4: likelihood ratios , 2004, BMJ : British Medical Journal.

[62]  A. Çamsarı,et al.  Increased levels of high sensitive C‐reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation , 2002, European journal of heart failure.

[63]  P. I. Jiménez,et al.  [C reactive protein as marker of infection among patients with severe closed trauma]. , 2001, Enfermedades infecciosas y microbiologia clinica.

[64]  J. Vincent,et al.  The Time Course of Blood C-reactive Protein Concentrations in Relation to the Response to Initial Antimicrobial Therapy in Patients with Sepsis , 2008, Infection.

[65]  Irving Kushner,et al.  C-reactive Protein* , 2004, Journal of Biological Chemistry.

[66]  M. Meisner,et al.  Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients , 2005, Critical care.

[67]  C. Carlson,et al.  Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. , 2006, JAMA.

[68]  A. Sheriff,et al.  CRP and the disposal of dying cells: Consequences for systemic lupus erythematosus and rheumatoid arthritis , 2007, Autoimmunity.

[69]  T. Wyller,et al.  Is the concentration of C-reactive protein in bacteraemia associated with age? , 2008, Immunity & Ageing.

[70]  C-reactive protein concentration as a predictor of intensive care unit readmission: a nested case-control study. , 2006, Journal of critical care.

[71]  J. Vincent,et al.  Relationship between CRP and hypofibrinolysis: Is this a possible mechanism to explain the association between CRP and outcome in critically ill patients? , 2004, Thrombosis journal.

[72]  J. Decruyenaere,et al.  Dynamics of C-reactive protein and white blood cell count in critically ill patients with nosocomial Gram positive vs. Gram negative bacteremia: a historical cohort study , 2007, BMC infectious diseases.

[73]  P. Ridker,et al.  Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery. , 2007, Journal of vascular surgery.

[74]  R. Paladini,et al.  Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis. , 2006, Minerva anestesiologica.

[75]  J. Vincent,et al.  Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver. , 2005, The Journal of laboratory and clinical medicine.

[76]  N Rifai,et al.  Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. , 2001, Clinical chemistry.

[77]  Thomas Francis,et al.  SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS , 1930, The Journal of experimental medicine.

[78]  P. Box.  Corticosteroids for the prevention of atrial fibrillation after cardiac surgery:A randomized controlled trial , 2007 .